Stock screenerAll disclosures →
EDGAR →
CUE
Conviction 96HealthcareScan · Thu, Jun 25, 2026Bearish belt hold
CUE$25.87-0.54%
ResistanceSupportVol 14Insider buy2
Vol MA14 90.77K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price25.87
Change-0.54%
Gap+4.61%
Rel volume2.91×
Avg volume92.42K
Avg $ vol2.47M
SMA 2026.83
SMA 5021.99
SMA 2005.86
Price vs 50+17.64%
Price vs 200+341.47%
MA stackbullish
50/200 cross—
Supertrendup · 19.79
RSI (14)51
MACD hist-0.49
MACD crossbear · 9d
Stoch %K / %D27 / 31
ADX (14)34
+DI / −DI25 / 13
RSI divergenceBearish
MACD divergenceBearish
ATR %+14.70%
ADR %14.07%
52w high35.73
52w low0.1770
From 52w high-27.60%
Above 52w low+14515.82%
New 52w highNo
SqueezeOn · 1d
Bollinger width36.70%
%B0.40
Donchian pos45.05%
Donchian high33.03
Donchian low20.00
AVWAP (52w high)28.53
vs AVWAP high-9.34%
AVWAP (52w low)2.05
vs AVWAP low+1163.99%
OBV trendFlat
Chaikin MF (20)0.14
Today vs 20d2.91×
Avg vol (14d)90.77K
Avg vol (20d)92.42K
Avg $ vol (20d)2.47M
Market cap104.66M
RS 3m (vs SPY)+10091.74%
RS 6m (vs SPY)+9590.25%
RS line new highNo
Trend template7/8
Technical rank90.7
1 week-3.22%
1 month+29.16%
3 months+9691.82%
6 months+10101.10%
1 year+3476.66%
YTD+7567.46%
P/E-3.93
P/B4.84
P/S3.81
P/FCF-4.79
EPS-0.2800
Div yield—
ROE-123.11%
ROA-86.15%
Debt/Eq0.19
Current3.57
EV/EBITDA-3.61
Gross margin—
Net margin-96.85%
Rev growth195.75%
EPS growth34.60%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value92.28M
Revenue5.69M
Net income-5.18M
Gross profit—
Free cash flow-21.86M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out4.2M
Employees29
ListedTue, Jan 2, 2018
Free float94.71M
Float %97.2%
Short interest277.69K
Days to cover2.6d
Short volume57.4%
Squeeze score40 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA+
Conviction96 / 100
Pattern quality—
Tech rank90.7 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBearish belt hold
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CUE
No recent disclosed trades by Congress in CUE. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CUE · 9 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Camardo Daniel A. Director · Stock Option (Right to Buy) · 2026-05-30 | Grant | 1.63K | $0 | 2026-05-30 | 2026-06-08 |
Lin Shao-Lee Chief Executive Officer · Common Stock Warrants (Right to Buy) · 2026-06-01 | Buy | 45.45K | — | 2026-06-01 | 2026-06-03 |
Lin Shao-Lee Chief Executive Officer · Pre-Funded Warrants (Right to Buy) · 2026-06-01 | Buy | 90.91K | $1000K | 2026-06-01 | 2026-06-03 |
Meehan Viola Mong Director · Stock Option (Right to Buy) · 2026-05-30 | Grant | 1.63K | $0 | 2026-05-30 | 2026-06-02 |
Lin Shao-Lee CHIEF EXECUTIVE OFFICER · Stock Option (right to buy) · 2026-05-03 | Grant | 655.07K | $0 | 2026-05-03 | 2026-05-07 |
Lin Shao-Lee CHIEF EXECUTIVE OFFICER · Common Stock · 2026-05-03 | Grant | 327.54K | $0 | 2026-05-03 | 2026-05-07 |
Baker Daniel G. CHIEF DEVELOPMENT OFFICER · Stock Option (right to buy) · 2026-04-09 | Grant | 100K | $0 | 2026-04-09 | 2026-04-10 |
Sandercock Colin SVP, GENERAL COUNSEL · Stock Option (right to buy) · 2026-04-09 | Grant | 200K | $0 | 2026-04-09 | 2026-04-10 |
Warren Lucinda CHIEF BUSINESS OFFICER · Stock Option (right to buy) · 2026-04-09 | Grant | 250K | $0 | 2026-04-09 | 2026-04-10 |
SEC filings
EDGAR filings in CUE · 4 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.